Yahoo
XETRA - Delayed Quote EUR

M1 Kliniken AG (M12.DE)

19.26 -0.30 (-1.53%)
As of 2:30:15 PM GMT+1. Market Open.
Chart Range Bar
Loading chart for M12.DE
  • Previous Close 19.56
  • Open 19.50
  • Bid 19.10 x 150000
  • Ask 19.26 x 75500
  • Day's Range 19.12 - 19.50
  • 52 Week Range 13.62 - 21.70
  • Volume 798
  • Avg. Volume 3,359
  • Market Cap (intraday) 357.371M
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) 18.88
  • EPS (TTM) 1.02
  • Earnings Date --
  • Forward Dividend & Yield 1.20 (6.14%)
  • Ex-Dividend Date Jul 9, 2026
  • 1y Target Est --

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.

www.m1-kliniken.de

280

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

M12.DE
8.42%
DAX P (^GDAXI)
5.58%

1-Year Return

M12.DE
29.73%
DAX P (^GDAXI)
7.92%

3-Year Return

M12.DE
161.45%
DAX P (^GDAXI)
70.74%

5-Year Return

M12.DE
169.14%
DAX P (^GDAXI)
62.06%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY23
Revenue 76.8M
Earnings --
Profit Margin 0.00%

Q1

FY22

Q2

FY22

Q1

FY23

0
20M
40M
60M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.86%

  • Return on Assets (ttm)

    10.46%

  • Return on Equity (ttm)

    15.30%

  • Revenue (ttm)

    257.36M

  • Net Income Avi to Common (ttm)

    20.23M

  • Diluted EPS (ttm)

    1.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    60.5M

  • Total Debt/Equity (mrq)

    3.88%

  • Levered Free Cash Flow (ttm)

    24.08M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: